Cardinal Health completes acquisition of Integrated Oncology Network

ION accelerates development of Navista, integrating more than 100 providers at more than 50 community-based sites across 10 states into oncology practice alliance.

DUBLIN, Ohio, Dec. 3, 2024 - Cardinal Health (NYSE: CAH) announced today that it has completed its acquisition of Integrated Oncology Network (ION). ION is a physician-led independent community oncology network including more than 100 providers delivering care at more than 50 practice sites across 10 states. ION supports a complete continuum of care across its member sites including medical oncology, radiation oncology, surgical oncology, urology, diagnostic testing and other ancillary services. As part of the transaction ION practices will be integrated into Navista, Cardinal Health's oncology practice alliance, and ION practice management and practice growth services will become part of Navista's advanced services and technology offering. The ION team will join the Pharmaceutical and Specialty Solutions segment of Cardinal Health.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.

Contacts
Media: Andrea Bunce, [email protected] and (614) 553-3853
Investors: Matt Sims, [email protected] and (614) 553-3661